ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online before print April 11, 2007, 10.1183/09031936.00129806
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
30/1/26    most recent
09031936.00129806v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Permissions
Right arrowRequest Permissions
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (1)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tiev, K. P.
Right arrow Articles by Dinh-Xuan, A. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tiev, K. P.
Right arrow Articles by Dinh-Xuan, A. T.
Eur Respir J 2007; 30:26-30
Copyright ©ERS Journals Ltd 2007

Severity of scleroderma lung disease is related to alveolar concentration of nitric oxide

K. P. Tiev1, J. Cabane1, F. Aubourg2, A. Kettaneh1, M. Ziani1, L. Mouthon3, S. Duong-Quy2, I. Fajac2, L. Guillevin3 and A. T. Dinh-Xuan2

1 Dept of Internal Medicine, Faculty of Medicine, Université Paris Pierre et Marie Curie, Hôpital Saint-Antoine, and Depts of 2 Respiratory Physiology, and 3 Internal Medicine, Faculty of Medicine, Université Paris Descartes, Hôpital Cochin, Paris, France.

CORRESPONDENCE: A. T. Dinh-Xuan, Dept of Respiratory Physiology, Faculty of Medicine, EA 2511, Université Paris Descartes, Hôpital Cochin, 27, rue du faubourg Saint-Jacques, 75679, Paris Cedex 14, France. Fax: 33 158412345. E-mail: anh-tuan.dinh-xuan{at}cch.aphp.fr

Keywords: Exhaled nitric oxide, interstitial lung disease, nitric oxide, systemic sclerosis

Received: October 4, 2006
Accepted March 25, 2007

The alveolar concentration of exhaled nitric oxide (CA,NO) is increased in patients with systemic sclerosis (SSc), but whether this increase is related to the severity of interstitial lung disease (ILD) in SSc has not yet been investigated.

In total, 58 SSc patients prospectively underwent pulmonary function tests (PFTs), echocardiogram and fibrosis scoring on pulmonary computed tomography (CT). Patients were divided into two groups according to the presence (or not) of ILD. Measurements of CA,NO were assessed in all SSc patients and compared with those obtained in 19 healthy volunteers. Relationships were sought between CA,NO PFTs and CT scan fibrosis scores.

Overall, CA,NO was significantly increased in SSc patients (median (range) 6.2 (3.8–9.9) ppb) as compared with controls (2.0 (1.2–3.0) ppb). Among SSc patients, CA,NO was significantly higher in patients with ILD compared with patients without ILD (n = 33, 7.5 (5.2–11.9) ppb versus n = 25, 4.9 (3.1–7.0) ppb, respectively). CA,NO was inversely related to total lung capacity (r = –0.34) and the diffusing capacity of the lung for carbon monoxide (r = –0.37) and was directly related to CT scan fibrosis scores (r = 0.36).

An increased alveolar concentration of exhaled nitric oxide could, at least in part, either reflect or contribute to the severity of lung disease and could be used to noninvasively assess the extent of interstitial lung disease in systemic sclerosis.




This article has been cited by other articles:


Home page
ERRHome page
P-R. Burgel, J. de Blic, P. Chanez, C. Delacourt, P. Devillier, A. Didier, J-C. Dubus, I. Frachon, G. Garcia, M. Humbert, et al.
Update on the roles of distal airways in asthma
Eur. Respir. Rev., June 1, 2009; 18(112): 80 - 95.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
T. Dimitroulas, G. Giannakoulas, T. Sfetsios, H. Karvounis, H. Dimitroula, G. Koliakos, and L. Settas
Asymmetrical dimethylarginine in systemic sclerosis-related pulmonary arterial hypertension
Rheumatology, November 1, 2008; 47(11): 1682 - 1685.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the European Respiratory Society.